Are the disparate pharmacological profiles of competitive and un-competitive NMDA antagonists due to different baseline activities of distinct glutamatergic pathways? (Hypothesis).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples